Processa Pharmaceuticals (PCSA) Notes Payables (2012 - 2021)
Processa Pharmaceuticals' (PCSA) quarterly Notes Payables came in at $144888.0 in Q1 2021, up 23.23% on a QoQ basis from $117574.0 in Q4 2020.
Processa Pharmaceuticals (PCSA) Notes Payables (2012 - 2021) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 8 years of Notes Payables data on file, last reported at $144888.0 in Q1 2021.
- Quarterly Notes Payables changed N/A year-over-year to $144888.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $144888.0 (changed N/A YoY) and the FY2020 annual result came in at $117574.0, changed N/A from the prior year.
- Notes Payables advanced to $144888.0 in Q1 2021, from $117574.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.0 million in Q2 2017 to a low of $72203.0 in Q2 2020.
- A 3-year average of $404119.3 and a median of $131231.0 in 2020 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 7.79% in 2017, down 0.0% in 2017.
- Tracing PCSA's Notes Payables over 3 years: stood at $1.0 million in 2017, then sank by 88.67% to $117574.0 in 2020, then increased by 23.23% to $144888.0 in 2021.
- The last three Notes Payables figures came in at $144888.0 (Q1 2021), $117574.0 (Q4 2020), and $90329.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Processa Pharmaceuticals | 6.05 Mn | 6.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 144,888.00 |
| Dec 31, 2020 | 117,574.00 |
| Sep 30, 2020 | 90,329.00 |
| Jun 30, 2020 | 72,203.00 |
| Jun 30, 2017 | 1.04 Mn |
| Mar 31, 2017 | 962,361.00 |
| Dec 31, 2016 | 962,361.00 |
| Sep 30, 2016 | 962,361.00 |
| Jun 30, 2016 | 962,361.00 |
| Mar 31, 2016 | 962,361.00 |
| Dec 31, 2015 | 947,361.00 |
| Sep 30, 2015 | 947,361.00 |
| Jun 30, 2015 | 908,361.00 |
| Mar 31, 2015 | 908,361.00 |
| Dec 31, 2014 | 160,000.00 |
| Sep 30, 2014 | 250,000.00 |
| Jun 30, 2014 | 250,000.00 |
| Mar 31, 2014 | 500,000.00 |
| Dec 31, 2013 | 500,000.00 |
| Sep 30, 2013 | 1.00 Mn |